Umbilical cord blood banking and derived treatment
- Submission status
- Open
- Submission deadline
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.
This Scientific Reports Collection invites original research focused on umbilical cord blood banking and its implications for regenerative medicine and therapy. Narrative review articles are also welcomed for submission to our sister journal Scientific Reviews. For further information, please view the ‘Participating Journals’ below.
Umbilical cord blood (UCB) is a rich source of stem cells, essential for treating various haematological disorders, including leukaemia and lymphoma. The unique properties of UCB, including its lower risk of graft-versus-host disease, present transformative potential for patient treatment and recovery. Submissions may investigate the efficacy of UCB-derived stem cells, improvements in banking protocols, or explore the potential of mesenchymal stem cells (MSCs) in addressing various medical conditions.
